103 related articles for article (PubMed ID: 6104907)
1. Progress in the pharmacotherapy of Parkinsonism.
Calne DB; Eisler T; Gopinathan G; Williams A
Adv Biochem Psychopharmacol; 1980; 23():237-43. PubMed ID: 6104907
[No Abstract] [Full Text] [Related]
2. [Considerations in the drug treatment of parkinsonism (author's transl)].
Hungerbühler JP; Regli F
Schweiz Rundsch Med Prax; 1978 Nov; 67(45):1648-57. PubMed ID: 30976
[No Abstract] [Full Text] [Related]
3. Treatment of parkinsonism.
Calne DB; Teychenne PF; Pfeiffer RF
Adv Exp Med Biol; 1977; 90():49-61. PubMed ID: 930750
[No Abstract] [Full Text] [Related]
4. [Recent progress of therapy in patients with Parkinson's disease].
Yanagisawa N
Nihon Naika Gakkai Zasshi; 1993 Jul; 82(7):1109-14. PubMed ID: 8228492
[No Abstract] [Full Text] [Related]
5. Combination treatment with selective monoamine oxidase inhibitors and dopaminergic agonists in Parkinson's disease: biochemical and clinical observations.
Riederer P; Jellinger K; Danielczyk W; Seemann D; Ulm G; Reynolds GP; Birkmayer W; Koppel H
Adv Neurol; 1983; 37():159-76. PubMed ID: 6407285
[No Abstract] [Full Text] [Related]
6. Clinical studies with bromocriptine in idiopathic parkinsonism.
Teychenne PF; Kartzinel R; Perlow M; Pfeiffer R; Calne DB
Trans Am Neurol Assoc; 1976; 101():302-4. PubMed ID: 1037483
[No Abstract] [Full Text] [Related]
7. Bromocriptine:dopamine-receptor agonist.
Dipalma JR
Am Fam Physician; 1976 Dec; 14(6):88-9. PubMed ID: 1036662
[No Abstract] [Full Text] [Related]
8. Parkinson's disease: new treatments.
Stewart RM
Compr Ther; 1981 Apr; 7(4):38-44. PubMed ID: 7237986
[TBL] [Abstract][Full Text] [Related]
9. MAO-B inhibitors in Parkinson's disease.
Olanow CW
Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
[No Abstract] [Full Text] [Related]
10. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
11. [Drug therapy of Parkinson disease and parkinson disease-like symptoms].
Kehr W
Arzneimittelforschung; 1981; Suppl 27():26-33. PubMed ID: 7197938
[No Abstract] [Full Text] [Related]
12. [Treatment of parkinsonism with dopaminergic system agonists].
Dowzenko A
Neurol Neurochir Pol; 1976; 10(4):579-82. PubMed ID: 958587
[No Abstract] [Full Text] [Related]
13. [Letter: Efficacy of bromocriptine in 2 cases of levodopa-resistant parkinsonism].
Kissel P; Andre JM; Jacquier A
Nouv Presse Med; 1976 Jan; 5(4):210. PubMed ID: 1264671
[No Abstract] [Full Text] [Related]
14. Developments in the treatment of parkinsonism.
Calne DB
N Engl J Med; 1976 Dec; 295(25):1433-4. PubMed ID: 989886
[No Abstract] [Full Text] [Related]
15. Letter: Bromocriptine in parkinsonism.
Debono AG; Donaldson I; Marsden CD; Parkes JD
Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
[No Abstract] [Full Text] [Related]
16. Role of ergot derivatives in the treatment of parkinsonism.
Calne DB
Fed Proc; 1978 Jun; 37(8):2207-9. PubMed ID: 658459
[No Abstract] [Full Text] [Related]
17. [Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].
García de Yébenes J; Avila C; Bazán E; García E; Gervás J; Maseda C; Mena M; Muradas V; Ramos JA
Med Clin (Barc); 1982 Apr; 78(7):259-64. PubMed ID: 7087591
[No Abstract] [Full Text] [Related]
18. Letter: Bromocriptine in parkinsonism.
Lees AJ; Shaw KM; Stern GM
Lancet; 1975 Oct; 2(7937):709-10. PubMed ID: 52084
[No Abstract] [Full Text] [Related]
19. Letter: Growth-hormone response to bromocriptine in parkinsonism.
Shaw KM; Lees AJ; Hayes S; Ross EJ; Stern GM; Thompson BD
Lancet; 1976 Jan; 1(7952):194. PubMed ID: 54702
[No Abstract] [Full Text] [Related]
20. International guide to drugs for Parkinson's disease.
Oertel WH; Dodel RC
Mov Disord; 1995 Mar; 10(2):121-31. PubMed ID: 7753054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]